Fundraising FoxJoyance Partners — 2021 Investments
10 investments dated 2021 · listed companies and verified rows first · show all
Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.
BiotechDeep TechDigital HealthSan Diego, US
Co-investorsALS Investment FundPsyMed VenturesSocial StartsApollo Health VenturesLeaps by Bayer
Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease.
AI & Machine LearningBiotechDigital HealthHealthtechLongevitySan Mateo, US
David Furman, PhD(Co-Founder & Chairman of the Scientific Advisory Board)Mark Davis, PhD(Co-Founder & Scientific Advisory Board Member)inWolfgang Daum(Executive Officer, Director)inDavid Goldberg(CEO)inDavid Furman(Director)
BoardNaveen Krishnan(Director)in
Co-investorsBetter Food VenturesPaladin Capital GroupSocial StartsAhren Innovation CapitalLeaps by BayerVertical Venture Partners
Lark develops an AI-powered health coaching platform that delivers personalized support for chronic disease prevention and management through 24/7 text-based conversations and integration with smart health devices.
AI & Machine LearningDigital HealthHealthtechMountain View, US
Julia Hu(CEO, Co-founder)inJeff Zira(CTO, Co-founder)
Co-investorsAlpha Intelligence CapitalAsset Management CompanyIPD CapitalKing River CapitalOlive Tree CapitalSamsung Next+8 more
Mine'd is an emotional wellness app connecting users with vetted wellness experts through live and on-demand classes.
Wellness & FitnessNew York City, US
Aaron Albert(Executive Officer, Director)Mark Groves(Executive Officer)Matthew Sadofsky(Director)
BoardJeff Cantalupo(Director)in
Co-investorsSocial StartsTechstarsAble PartnersListen VenturesRoute 66 VenturesWndrCo
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)inShriram Raghunathan(Executive Officer, Director)
BoardChau Khuong(Director)inAllan May(Director)Mudit Jain(Director)inTracy Pappas(Director)in
Co-investorsAngelini VenturesBlue Venture FundsOrbiMedTreo Ventures, LlcZühlke VenturesBridge Bank+2 more
Sigrid Therapeutics develops non-pharmaceutical solutions for blood sugar control and weight management using its patented SiPore silica technology, which slows the digestion of carbohydrates and fats in the gut.
HealthtechMedical DevicesWellness & Fitness
Sana Alajmovic(Co-founder & CEO)
Co-investorsAtaraxia VC
Thryve provides a platform that enables partners to improve patient engagement, preventive care, and clinical research through real-world health insights and insurance innovation.
Data & InfrastructureDigital HealthHealthtechBerlin, DE
Friedrich Lämmel(CEO)inJohn Trimpop(CTO)Paul Burggraf(COO)in
Co-investorsCARMA FUNDKickstart InnovationAbstract VenturesDarling VenturesOpenspace VenturesPIVOTNORTH+4 more
THRYVE Automation designs and builds custom turnkey automation systems—including robotics, machine vision, material handling, inspection, and packaging—for manufacturers in energy, life sciences, HVAC/filtration, automotive, and consumer products.
Advanced ManufacturingHardwareRoboticsRichmond, US
Co-investorsMcNally CapitalAbstract VenturesDarling VenturesOpenspace VenturesPIVOTNORTHShanda Group+3 more
Zone7 develops data and AI-powered products to optimize performance and durability for high-performance teams.
AI & Machine LearningEnterprise SoftwareHealthtechHR TechSports TechPalo Alto, US
Tal Brown(CEO & Co-Founder)inEyal Eliakim(CTO & Co-Founder)in
BoardBruce Taragin(Director)in
Co-investorsAlumni VenturesArba LLCBlumberg CapitalResolute VenturesSocial StartsUpWest+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.